By Joanne Beck, Ph.D., Executive Vice President, Global Pharmaceutical Development & Operations, Celgene Corporation
The highly-regulated nature of the pharmaceutical industry – coupled with historically siloed organizational models and mergers and acquisitions that introduce disparate operational and IT systems to the enterprise.
By Tom O’Leary, CIO, ICON
In the context of Pharmaceutical Drug Development the big challenge is connecting and integrating technologies which will give a full 360 degree perspective on the patient and ultimately deliver an Integrated Healthcare Ecosystem.
By Christian Burns, Director of Clinical Operations and Patient Recruitment, ClinEdge
The clinical research industry is witnessing a shift in how sponsors, research clinics, and patients collaborate.
By Michael Swanick, Global Pharmaceutical and Life Sciences Industry Leader, PwC
Technological advances, empowered consumers, disruptive new entrants, and rising demand by an aging population are ushering in a new era in healthcare—what we at PwC call the “New Health Economy.”
By Judy Murrah, CIO, Applied DNA Sciences Inc
The Internet of Things is focused on smart things. “Unintelligent” things such as pharmaceuticals need a voice to ensure that they are real, safe, and traceable.
By Damian Skelton, Area Vice President, Medxcel Facilities Management
Making a decision based on second-hand experience, manufacture sales pitches or un-vetted third-party recommendations are dangerous.
By Terry Godier, Medical practitioner, mybiosource.com
ELISA is a popular acronym for an enzyme-linked immunosorbent test that detects as well as measures antibodies in the blood.
By Fadi Elawar, Technical Consultants Team Lead, iDashboards
Today, business intelligence solutions continue to grow more powerful and sophisticated, tracking variables with greater precision while gathering enormous amounts of information in real time.
By Paul Shawah, VP, Commercial Cloud Strategy, Veeva Systems and President at Align Bio-pharma
The life science industry’s commercial model has transformed significantly over the past decade.
By Bozidar Jovicevic, VP, Global Head of Digital Medicines, Sanofi
Technology has aided the pharma and life sciences industry in employing genomics and artificial intelligence (AI) for speeding up drug R&D course.